About

Biodexa Pharmaceuticals is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain

Driven by a team of scientists and pharmaceutical development specialists, and led by an experienced management team, Biodexa Pharmaceuticals is progressing a pipeline of differentiated therapeutics in areas of high unmet need for the benefit of patients.

The Team

Core to Biodexa Pharmaceuticals strength is its highly experienced and dedicated team.

The Biodexa Pharmaceuticals team benefits from cross-functional expertise including formulation science and pharmaceutical development. With over 10 years’ experience of working together the team has translated multiple programmes from concept to clinic across three distinct technology platforms and apply extensive knowledge and expertise to deliver rapid R&D innovation and value creation.